Nifedipine ER is an extended-release form of nifedipine, a medication that lowers blood pressure and eases chest pain by relaxing the smooth muscle in artery walls. The “ER” designation means the tablet is engineered to release the drug gradually over a full day, so you take it once rather than multiple times. This slow-release design is not just a convenience feature; it solved a real safety problem with older, fast-acting nifedipine capsules that could cause dangerous blood-pressure swings. Understanding how the tablet works, what it treats, and what to watch out for can help you use it more safely and have a more productive conversation with your prescriber.
How Nifedipine Works
Nifedipine belongs to a family of drugs called calcium channel blockers, specifically the dihydropyridine subtype. Calcium ions flowing into the smooth muscle cells lining your arteries are what make those muscles contract and narrow the vessel. Nifedipine blocks the channels those ions use, which keeps the muscle relaxed and the artery open. The result is wider blood vessels, lower resistance to blood flow, and reduced blood pressure. Traditional calcium channel blockers like nifedipine act primarily on L-type calcium channels in blood vessels, making them potent vasodilators.1Cardiovascular Prevention and Pharmacotherapy. Calcium channel blockers for hypertension: old, but still useful
What sets nifedipine apart from related calcium channel blockers like verapamil and diltiazem is where it acts most strongly. Verapamil and diltiazem have significant effects on the heart’s electrical system, slowing the heart rate and the speed at which electrical signals travel through the heart. Nifedipine, by contrast, is overwhelmingly a blood-vessel drug. In clinical studies comparing these agents, nifedipine actually facilitates conduction through the heart’s atrioventricular node and shortens its refractory period, which is the opposite of what verapamil does.2PubMed. Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review That paradox is explained by a reflex: when nifedipine drops blood pressure, the nervous system responds by speeding up the heart. Verapamil’s direct depressant effect on the heart overwhelms that reflex, but nifedipine’s weaker direct cardiac effect does not.3PubMed. Heart rate-dependent atrioventricular nodal conduction and the effects of calcium channel blocking drugs: comparison of verapamil and nifedipine
Why the Extended-Release Formulation Matters
Old-style nifedipine capsules released the drug quickly, causing a rapid drop in blood pressure. The body interpreted that plunge as an emergency and fired off a burst of adrenaline-like activity, raising the heart rate and sometimes triggering chest pain or other cardiovascular events. The sympathetic activation triggered by short-acting nifedipine is substantially greater than what occurs with the extended-release version, precisely because the blood-pressure drop is so abrupt.4PubMed Central. Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease Those short-acting capsules are essentially no longer used for chronic conditions like high blood pressure.
The extended-release tablet solves this by using an osmotic pump design called the gastrointestinal therapeutic system, or GITS. The tablet has a laser-drilled hole, a drug layer, and an expanding polymer layer. As the tablet absorbs water in your gut, the polymer swells and steadily pushes the drug out through the tiny hole over roughly 24 hours.5PubMed. Nifedipine gastrointestinal therapeutic system Long-acting formulations like this gradually release nifedipine over a full day, smoothing out blood levels and avoiding the peaks and valleys that caused problems with older capsules.6PubMed Central. Long-acting nifedipine in the management of essential hypertension: a review for cardiologists
Because the tablet’s structure is what controls the release, you should never crush, split, or chew a nifedipine ER tablet. Doing so destroys the controlled-release mechanism and dumps the entire day’s dose into your bloodstream at once. This is not a theoretical concern: crushing extended-release nifedipine has been associated with documented fatalities.7Patient Safety. Nifedipine Errors and Serious Patient Harm: Insights From the Pennsylvania Patient Safety Reporting System and Potential Mitigation Strategies8PubMed. Fatality from administration of labetalol and crushed extended-release nifedipine If you have difficulty swallowing tablets, talk to your pharmacist about alternatives rather than altering the tablet yourself. You may also notice the empty tablet shell in your stool, which is normal and does not mean the drug was not absorbed.
Primary Uses
Nifedipine ER is prescribed mainly for two conditions: high blood pressure and a type of chest pain called angina.
For hypertension, it works as well as other long-acting calcium channel blockers. In a trial comparing nifedipine GITS with extended-release felodipine, both drugs lowered blood pressure by a similar amount, and roughly 80 percent of patients in both groups achieved an adequate blood-pressure response.9PubMed. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension Different extended-release nifedipine formulations also perform comparably to each other, with diastolic blood pressure dropping by roughly 13 to 15 mmHg after several weeks of treatment.10PubMed. Prospective controlled trial of two nifedipine extended release formulations in the treatment of essential hypertension
For angina, nifedipine is especially useful in vasospastic angina, sometimes called Prinzmetal’s angina, where chest pain occurs because a coronary artery temporarily spasms shut rather than being blocked by plaque. A systematic review of calcium channel blockers for vasospastic angina found that nifedipine decreased vasospastic episodes by the fourth and eighth weeks of treatment.11PubMed Central. Comparison of various calcium antagonist on vasospastic angina: a systematic review By keeping the coronary artery relaxed, nifedipine prevents the spasm from happening in the first place.
Off-Label Uses
Physicians also prescribe nifedipine for conditions beyond its formal approvals. Two of the most common off-label uses are Raynaud’s phenomenon and preterm labor.
Raynaud’s Phenomenon
Raynaud’s causes episodes where small arteries in the fingers and toes spasm in response to cold or stress, turning them white or blue and sometimes causing significant pain. Because nifedipine relaxes arterial smooth muscle, it can reduce both the frequency and severity of these attacks. In one early trial, the average number of vasospastic attacks per week dropped from about 27 to about 6 during nifedipine treatment.12PubMed. Calcium entry blocking agents in digital vasospasm (Raynaud’s phenomenon) A separate placebo-controlled study confirmed that nifedipine at 10 mg four times daily was well tolerated and significantly reduced both the frequency and severity of attacks compared with placebo.13PubMed. Clinical and laboratory effects of nifedipine in Raynaud’s phenomenon In practice, extended-release formulations are now more commonly used than the four-times-daily dosing from those older trials.
Preterm Labor
Nifedipine is widely used as a tocolytic, a drug given to slow or stop premature contractions and buy time for the fetus to mature. Because the uterus is a smooth-muscle organ, the same calcium-channel-blocking action that relaxes blood vessels also quiets uterine contractions. A systematic review and meta-analysis found that nifedipine reduced the risk of delivery within seven days of starting treatment and lowered rates of several serious newborn complications, including respiratory distress syndrome and admission to the neonatal intensive care unit, compared with older tocolytics.14American Journal of Obstetrics and Gynecology. Nifedipine in the management of preterm labor: a systematic review and metaanalysis A more recent meta-analysis found nifedipine to be superior to some other tocolytics and comparable in effectiveness to magnesium sulfate, with the choice between them often coming down to which drug a particular patient tolerates better.15PubMed Central. Comparison of the efficacy of nifedipine with ritodrine, nitroglycerine and magnesium sulfate for the management of preterm labor: a systematic review and meta-analysis In a recent study of 138 women with preterm labor, tocolysis with nifedipine was successful in about 85 percent of cases, with the vast majority delivering vaginally and experiencing only mild, manageable side effects.16PubMed Central. Efficacy and Safety of Nifedipine as a Tocolytic Agent in Preterm Labor
Common Side Effects
The most frequently reported side effects of nifedipine ER are directly related to its blood-vessel-relaxing action. Headache, flushing, and dizziness all stem from the same vasodilation that lowers blood pressure. These tend to be most noticeable when you first start the medication or when the dose is increased, and they often fade as your body adjusts.
Peripheral edema, the puffy swelling that typically shows up in the ankles and feet, is one of the more persistent side effects. It is not caused by fluid retention the way salt or heart failure might cause it. Instead, it results from an imbalance in how nifedipine affects different parts of the circulation: the drug opens the arterioles coming into the capillary beds more than it opens the venules draining out. That mismatch raises pressure inside the capillaries and pushes fluid into the surrounding tissue. This type of edema is more common in women, tends to be worse when standing for long periods, and is dose-dependent.17PubMed Central. Calcium channel blocker-related periperal edema: can it be resolved? Diuretics generally do not help much because the problem is not excess total body fluid. Adding an ACE inhibitor or ARB, which dilates the venous side of the circulation, can partially offset the imbalance.
A less well-known side effect is gingival overgrowth, where the gum tissue becomes swollen and enlarged. Among calcium channel blockers, nifedipine is the one most commonly linked to this problem, with a reported incidence of roughly 38 percent.18Mayo Clinic Proceedings. Medically Induced Gingival Hyperplasia Good oral hygiene and regular dental cleanings can reduce the severity, but if the overgrowth becomes significant, switching to a different blood-pressure medication is often the most effective remedy.
The Grapefruit Interaction
Grapefruit juice is one of the more widely known food-drug interactions, and nifedipine is squarely on the list. Compounds in grapefruit inhibit enzymes in the gut wall that normally break down a portion of nifedipine before it reaches the bloodstream. The result is that more of the drug gets absorbed than intended, effectively giving you a higher dose than prescribed. Grapefruit juice increases the bioavailability of nifedipine, though interestingly, studies suggest it does so primarily by improving absorption rather than by slowing the drug’s metabolism once it is in the body.19PubMed. Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms A case report described clinically significant effects from the interaction in a patient who regularly drank grapefruit juice while taking nifedipine.20PubMed Central. Clinical effects of grapefruit juice-nifedipine interaction in a 54-year-old Nigerian: a case report The practical advice is straightforward: avoid grapefruit and grapefruit juice while you are taking nifedipine ER. Other citrus fruits like oranges are fine.
Stopping Nifedipine Abruptly
You should not stop taking nifedipine ER suddenly without medical guidance. Although rebound hypertension, a spike in blood pressure after discontinuing a medication, is more classically associated with drugs like clonidine, it can happen with nifedipine too. A case report documented a 71-year-old patient whose blood pressure surged to 300/200 mmHg three days after nifedipine was discontinued; while he had been on the drug, his pressure had stayed below 170/100.21JAMA Network. Hypertensive Crisis Associated With Nifedipine Withdrawal That is an extreme case, but it illustrates why tapering under a doctor’s supervision is the safer path if you need to come off the drug.
People with Liver Disease Need Lower Doses
Nifedipine is broken down almost entirely by the liver. In healthy individuals, the liver removes a large fraction of the drug during its first pass from the gut into the bloodstream. When liver function is impaired, far more of the drug survives that first pass and enters the circulation. A pharmacokinetic study in patients with liver cirrhosis found that oral bioavailability of nifedipine was about 91 percent in cirrhotic patients compared with roughly 51 percent in healthy subjects, and that the drug’s clearance from the body was cut by more than half.22PubMed. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration The effect was most pronounced in patients who had surgical shunts diverting blood around the liver.
Pharmacokinetic modeling work has estimated just how dramatic the dose adjustments need to be. For mild cirrhosis, the nifedipine dose may need to drop to roughly 44 percent of the standard healthy dose. In moderate cirrhosis, around 21 percent. In severe cirrhosis, the model predicted the dose should be about 10 percent of the standard amount, making nifedipine the most affected of four antihypertensive drugs studied.23PubMed Central. Using Physiologically Based Pharmacokinetic Modeling and Simulations to Predict Antihypertensive Drug Doses in Cirrhotic Patients If you have any degree of liver disease, your prescriber should start with a lower dose and monitor you more closely.
Nifedipine ER in Pregnancy-Related Hypertension
Beyond its tocolytic use described earlier, nifedipine ER is frequently used to manage high blood pressure in severe preeclampsia and the postpartum period. A randomized trial comparing once-daily nifedipine GITS 60 mg with the same total dose split into 30 mg twice daily in women with severe preeclampsia found that blood-pressure control over 24 to 48 hours was similar between the two regimens. However, women in the once-daily group were more likely to need emergency antihypertensive treatment (about 46 percent versus roughly 15 percent), suggesting the twice-daily split may provide steadier coverage throughout the day for this population.24Hypertension. Daily Versus BID Nifedipine GITS in Severe Preeclampsia: Randomized Controlled Trial
Postpartum hypertension is another setting where nifedipine ER is commonly used. A randomized trial comparing nifedipine ER to amlodipine, a longer-acting calcium channel blocker, for postpartum blood-pressure management found that the two drugs produced similar hospital stays and similar overall blood-pressure control. However, amlodipine was significantly less likely to be discontinued due to side effects (zero discontinuations versus about 10 percent for nifedipine ER), and hypotension and rapid heart rate were less common with amlodipine.25American Journal of Obstetrics & Gynecology MFM. Amlodipine versus nifedipine ER for the management of postpartum hypertension: a noninferiority randomized controlled trial These findings suggest nifedipine ER is effective in this setting but may carry a higher side-effect burden than alternatives.
How Nifedipine ER Compares to Amlodipine
Amlodipine is the calcium channel blocker people are most likely to see compared with nifedipine, and the differences are worth understanding. Both drugs are dihydropyridines that primarily relax blood vessels rather than acting on the heart. Both lower blood pressure effectively. The key difference is pharmacokinetics: amlodipine has a much longer half-life, meaning it lingers in the body for days rather than hours. That long tail provides very smooth blood-level curves even without a controlled-release tablet, and it means a missed dose is less catastrophic.
In a head-to-head trial, amlodipine and nifedipine retard (an extended-release formulation) produced comparable blood-pressure reductions. But the incidence of side effects considered related to the drug was about 41 percent for nifedipine retard compared with 27 percent for amlodipine and 16 percent for placebo. Vasodilator-related complaints like headache, flushing, and dizziness were reported significantly more often with nifedipine retard than with either amlodipine or placebo.26PubMed. Comparison of early side effects with amlodipine and nifedipine retard in hypertension Amlodipine’s smoother blood-level profile likely explains why it triggers fewer vasodilatory side effects. These differences in tolerability, combined with once-daily convenience that does not depend on a special tablet design, have made amlodipine the more commonly prescribed of the two for garden-variety hypertension.
That said, nifedipine ER retains distinct clinical niches. Its faster onset compared to amlodipine makes it more practical for conditions where you need blood-pressure control within a day rather than over several days, such as the peripartum settings discussed above or acute management situations. It remains the go-to calcium channel blocker for vasospastic angina and Raynaud’s in many treatment guidelines, and its tocolytic role gives it a place in obstetric medicine that amlodipine simply does not occupy.
Typical Dosing
Nifedipine ER tablets are available in 30 mg, 60 mg, and 90 mg strengths. The GITS system delivers the drug at different hourly rates depending on the strength.5PubMed. Nifedipine gastrointestinal therapeutic system Most prescribers start at 30 mg once daily and increase every one to two weeks if blood pressure has not reached the target. The maximum dose for hypertension is typically 90 mg once daily, though some patients may be prescribed up to 120 mg.
For vasospastic angina, the starting dose is similar, and the dose is titrated upward based on symptom control. For Raynaud’s, doses tend to stay in the 30 to 60 mg range. In obstetric settings, dosing varies depending on whether the drug is being used to slow contractions or to manage blood pressure, and hospital protocols often specify shorter-acting oral doses for acute tocolysis before transitioning to extended-release formulations for sustained management.
Regardless of the indication, the tablet should be swallowed whole with water. Taking it with or without food does not meaningfully change absorption for most formulations. And, as noted earlier, it should never be crushed or split.